Study Information
| Title: | An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene  |
| Status: | Recruiting participants |
| Conditions: | Carcinoma, Non-Small-Cell Lung |
| Interventions: | Drug: PF-02341066; Drug: Pemetrexed; Drug: Docetaxel |
| Health Topics: | Adenocarcinoma of the Lung, Lung Cancer Overview, Squamous cell carcinoma of the lung |
Contact Information
Pfizer Investigational Site
Boston, MA 02114
Pfizer Investigational Site
Boston, MA 02115
Pfizer Investigational Site
Boston, MA 02215